About Horizon Therapeutics Plc

Horizon Therapeutics Plc is a biopharmaceutical company which is engaged in the research, development and market of pharmaceutical products. The medicines intend to treat arthritis, inflammation and orphan diseases. It distributes its products under the brands such as Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid, Ravicti, Rayos and Vimovo. The company was founded in 2008 and is headquartered in Dublin, Ireland.

At the moment the company generates 1292M USD in revenues.

On its last earning announcement, the company reported a profit of 0.28$ per share.

The book value per share is 5.16$

Horizon Therapeutics Plc website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
1292M 69.30% 115M 8.90% 46M 0.28 - - 178M 5.16 344M -15M 328M